Ginkgo Biloba Used As Neuroprotective Action In Vedas Technology

One of the world's oldest tree species is the Gingo biloba. Ginkgo trees have existed since the Permian Period, which lasted from 286 to 248 million years ago. The genus Ginkgo only has one living member Ginkgo biloba. Ginkgo biloba contains chemicals with medicinal potential due to their unusual structures. Along with linkedin and ginkgolides, these compounds also contain flavones, ginkgo ghrelins, and ginkgolide acids. Ginkgo flavone glycosides (ginkgetin, biotin, and sciadopitysin) and terpene lactones (ginkgolides and diterpenes) are the two primary components of Ginkgo biloba. Different elements have different quantities. Recent research has demonstrated that GBE inhibits Aβ-induced neurotoxicity by blocking many processes such as mitochondrial failure, ROS buildup, glucose absorption, AKT activation, JNK and ERK 1/2 pathways, and apoptosis—the benefits of G in preventive. Biloba extract inhibited the action of 6-hydroxydopamine, which stopped PC12 cells from dying in a Parkinson's disease model. According to several case reports, ginkgo usage is associated with bleeding episodes, including severe brain hemorrhage. Be careful when administering ginkgo to patients who are using anticoagulant or antiplatelet medication, have bleeding issues, or are using NSAIDs.